Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Intensity Therapeutics (INTS) Institutional Ownership

Intensity Therapeutics logo

Institutional Ownership Changes (13F Filings) for Intensity Therapeutics (NASDAQ:INTS)

Current
Institutional Ownership
Percentage
3.74%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$398.82K
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$717.10K
Get INTS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intensity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

INTS Institutional Buying and Selling by Quarter

Intensity Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2025Armistice Capital LLC872,547$1.72M0.0%-22.6%5.778%
5/8/2025Mesirow Financial Investment Management Inc.40,000$79K0.0%+100.0%0.265%
4/15/2025Sapient Capital LLC976,797$1.92M0.0%+3.6%6.469%
2/18/2025GTS Securities LLC19,030$34K0.0%-49.0%0.126%
2/17/2025Citadel Advisors LLC14,964$26K0.0%N/A0.099%
2/7/2025Mesirow Financial Investment Management Inc.20,000$35K0.0%-54.7%0.132%
2/3/2025Sigma Planning Corp54,837$97K0.0%+14.9%0.363%
1/29/2025Sapient Capital LLC942,841$1.66M0.0%-6.7%6.244%
11/16/2024Geode Capital Management LLC64,349$246K0.0%+35.1%0.467%
8/12/2024Blair William & Co. IL37,805$185K0.0%N/A0.276%
4/26/2024Mesirow Financial Investment Management Inc.44,177$230K0.0%N/A0.322%
4/23/2024Sapient Capital LLC1,012,069$5.26M0.1%+406.0%7.382%
2/9/2024Hohimer Wealth Management LLC44,779$384K0.1%-76.0%0.327%
2/6/2024Sapient Capital LLC200,000$1.71M0.0%N/A1.459%
2/1/2024Sigma Planning Corp34,443$295K0.0%-28.5%0.251%
1/29/2024Sapient Capital LLC200,000$1.71M0.1%N/A1.459%
11/21/2023Hohimer Wealth Management LLC186,464$740K0.2%N/A1.360%
11/6/2023Sigma Planning Corp48,144$191K0.0%N/A0.352%
(Data available from 1/1/2016 forward)

INTS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of INTS shares?

During the previous two years, 9 institutional investors and hedge funds held shares of Intensity Therapeutics. The most heavily invested institutionals were Sapient Capital LLC ($1.92M), Armistice Capital LLC ($1.72M), Hohimer Wealth Management LLC ($384K), Geode Capital Management LLC ($246K), Blair William & Co. IL ($185K), Sigma Planning Corp ($97K), and Mesirow Financial Investment Management Inc. ($79K).Learn more on Intensity Therapeutics' institutional investors.

What percentage of Intensity Therapeutics' stock is owned by institutional investors?

3.74% of Intensity Therapeutics' stock is owned by institutional investors. Learn more on INTS's institutional investor holdings.

Which institutional investors have been buying Intensity Therapeutics' stock?

The following institutional investors have purchased Intensity Therapeutics' stock in the last 24 months: Sapient Capital LLC ($1.25M), Hohimer Wealth Management LLC ($186.46K), Mesirow Financial Investment Management Inc. ($64.18K), Sigma Planning Corp ($55.24K), Blair William & Co. IL ($37.81K), Geode Capital Management LLC ($16.73K), and Citadel Advisors LLC ($14.96K).

How much institutional buying is happening at Intensity Therapeutics?

Institutional investors have bought a total of 130,547 shares in the last 24 months. This purchase volume represents approximately $398.82K in transactions.

Which of Intensity Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Intensity Therapeutics stock in the last 24 months: Armistice Capital LLC ($254.32K), Sapient Capital LLC ($67.91K), Mesirow Financial Investment Management Inc. ($24.18K), and GTS Securities LLC ($18.26K).

How much institutional selling is happening at Intensity Therapeutics?

Institutional investors have sold a total of 364,668 shares in the last 24 months. This volume of shares sold represents approximately $717.10K in transactions.



This page (NASDAQ:INTS) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners